Biostage, Inc.

Biostage, Inc.

BSTG - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$73.05M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Biostage, Inc.Biostage, Inc.-5.2--1235%-1.5

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$73.05 Million
Enterprise Value$72.01 Million
Earnings per Share$-0.42
Beta-0.97
Outstanding Shares18,127,103

Return

Return on Equity-1234.87%ROE
Return on Assets-203.41%
Return on Invested Capital-1260.92%

Valuation & Multiples

P/E Ratio-5.25P/E Ratio
PEG37.62PEG
Price to Sales-Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue83.83
Enterprise Value to EBIT-10.94
Enterprise Value to Net Income-12
Total Debt to Enterprise0.01
Debt to Equity1.54Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Harvard Apparatus Regenerative Technology Inc.

8 employees
CEO: Junli He

Harvard Apparatus Regenerative Technology Inc., a biotechnology firm currently conducting clinical trials, is dedicated to developing regenerative medical therapies. Its core mission involves addressing conditions affecting the gastroint...